John G. Morikis
At a glance: John G. Morikis is Director at Johnson & Johnson (JNJ). Their latest SEC Form 4, filed Dec 1, 2025, reported a purchase of $258K. On file: 1 purchase line ($258K) and 0 sale lines ($0).
Disclosed holdings: about $494K of JNJ stock: 1,849 shares reported on their latest Form 4 (filed Dec 1, 2025), valued at the Nov 19, 2026 close of $267.11. This counts only JNJ shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Johnson & Johnson (JNJ)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
John G. Morikis's InsiderPrint
4 trades from SEC Form 4 filings, 2022 to 2025, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $500K a trade.
- Bump outward: a purchase (4)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- David M. MauraCEO, Chair · SPB · 100% match
- Carlos E. EvansDirector · GSBD · 100% match
- Albert G. White IIICEO, President · COO · 100% matchTheir buys since 2020: 2 of 3 beat the S&P 500
- W. Bryan HillDirector · EQPT · 99% match
- Michael FiermanDirector · AOMR · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 1SEC | JNJJohnson & JohnsonFirst buyStake +209% | Buy | 1,2501,849 held (+209%) | $206.15 | $258K | +29.6% |
- Buy
Director John G Morikis bought $258K of JNJ at $206.15 — first open-market purchase in our records; raises the stake by 209%.
Follow John G. Morikis
Get one email when John G. Morikis files a new purchase or sale. Free.
At most one email a day about John G. Morikis, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.